Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Enhancing quality of antimicrobial prescribing through ‘Ask Eolas’ (language model): a user-testing and simulation evaluation
0
Zitationen
1
Autoren
2026
Jahr
Abstract
We aimed to assess prescribing accuracy, error reduction, usability, and clinician confidence of Ask Eolas (a retrieval-augmented generation-enhanced AI-CDSS) compared to existing antimicrobial guidance tools. We conducted a structured simulation single-site study evaluating Ask Eolas across 45 prescribing cases with healthcare professionals to assess prescribing accuracy. Among 45 participants, Ask Eolas achieved zero prescribing errors versus six and eight documented errors in the two comparator groups (Eolas App and PDF Guidelines) respectively (p<0.001). The number needed to treat was 1.9 for Ask Eolas versus traditional guidelines, indicating one additional error-free prescription for every two clinicians switching to Ask Eolas. Ask Eolas significantly improved prescribing accuracy while enhancing usability, clinician confidence, and system transparency compared to existing tools. These findings align with TRUST-AI framework principles for safe AI-CDSS deployment, supporting further investigation through real-world implementation studies incorporating live data integration, confidence calibration systems, and comprehensive auditability features in antimicrobial stewardship programs.
Ähnliche Arbeiten
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
2000 · 16.887 Zit.
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
2022 · 14.317 Zit.
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
2011 · 13.476 Zit.
Performance standards for antimicrobial susceptibility testing
2001 · 9.766 Zit.
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
2017 · 5.874 Zit.